ADARX PHARMACEUTICALS INC
Q3 2026 13F Holders
Symbol
ADRX
CUSIP
00654F105
Type
Equity
Class
COM
Num filings
1
Total reported value, excl. options
$399 k
Compare 2026 Q3 to
Manager
Report Date
Value ($000)
Shares
Option Type